Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALLO - Allogene Therapeutics GAAP EPS of $0.37 beats by $0.89 revenue of $0.04M beats by $0.03M
November, 02 2023 04:08 PM
Allogene Therapeutics Inc.
2023-11-02 16:08:38 ET
Allogene Therapeutics press release ( NASDAQ: ALLO ): Q3 GAAP EPS of $0.37 beats by $0.89 . Revenue of $0.04M (-20.0% Y/Y) beats by $0.03M . Company had $497.7 million in cash, cash equivalents, and investments as of September 30, 2023. Expects a decrease in cash, cash equivalents, and investments of approximately $230 million in 2023. Continues to expect its cash runway to fund operations into 2H 2025. For further details see:
Allogene Therapeutics GAAP EPS of $0.37 beats by $0.89, revenue of $0.04M beats by $0.03M
Stock Information
Company Name:
Allogene Therapeutics Inc.
Stock Symbol:
ALLO
Market:
NASDAQ
Website:
allogene.com
Get ALLO Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .